Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
is this a new trial referred to?
EU clinical register - search for sng001 and there is a start date of 08/10/2020 - have i read that right?
https://www.clinicaltrialsregister.eu/ctr-search/search?query=sng001
Also no mention of SNG in the SEPT EMS highlights
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-14-17-september-2020
Does anyone else think that the home trial might be expanded to get the numbers required to support any approvals. Just thinking about what was in Matt H's statement on the 20th July https://www.gov.uk/government/speeches/next-stages-in-the-nhs-test-and-trace-plan
Would we need to be informed as shareholders if so? The recruitment page is still open.......
no problem at all jint, as I said, i think we need to view it as interesting and informative and thats about it . My post following with in Nature is a good read also - refers to our trial too.
https://www.nature.com/articles/s41577-020-00429-3
the link i posted triggers a PDF to download which loads at the bottom of the page.
this link takes you to a page where you can click on 'download' - interesting info but i dont think we should read too much into it.
https://www.policyforum.labour.org.uk/commissions/governments-response-to-covid-19
New one to me - references the home trial by Synairgen by its number on the clinical trials website too
https://www.nature.com/articles/s41577-020-00429-3
Just having a look-see as you do and found this - no date, can't identify its purpose, who the author is etc but talks about Synairen in some detail. Would be interested in thoughts. Maybe a challenge paper?
https://www.google.co.uk/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjzkMSM6urrAhWHIMAKHcqbC4kQFjADegQIBBAB&url=https%3A%2F%2Fwww.policyforum.labour.org.uk%2Fcommissions%2Fgovernments-response-to-covid-19%3Fdownload%3Dtrue&usg=AOvVaw14j-GIglTVns5BNrYtc-u1
not offering any intepretation as that is not my area of expertise but might be of interest for those that have time
https://covid19.who.int/?gclid=CjwKCAjwtNf6BRAwEiwAkt6UQpXY8soU0UM_19Y2h2FuF53EFqC4_QLnNivAvPtvzU-FfPZBznalYhoCS2kQAvD_BwE
FDA issues draft guidance for industry on Drug-Drug Interaction Assessment for Therapeutic Proteins: https://go.usa.gov/xfHkG
Any thoughts?